ABCA4 and Abnormal retinal morphology: The complete genetic characterization of the patients will improve the accuracy of diagnosis and their counselling and also will assist in more effective patient selection of genetically confirmed participants for current and future clinical trials for ABCA4-associated retinal diseases.